| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |